Design Therapeutics, Inc 10-K for FY2022
Design Therapeutics, Inc. (DSGN)
10-K
2023-03-14
For: 2022-12-31
View Original
Added on
April 06, 2026
About this 10-K
Design Therapeutics, Inc filed this 10-K on March 14, 2023, covering the fiscal year ended December 31, 2022 (FY2022).
Headline figures
Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $63.31M
- compared with a net loss of $35.53M a year earlier
- Diluted EPS
- -$1.14
- compared with -$0.77 a year earlier